IC

Ian Chiang

Partner at Flare Capital Partners (Product & Innovation executive turned VC)

Greater Boston

Skills

Strategy
Start-ups
Mergers
Private Equity
Business Development
Business Planning
Management Consulting
Corporate Development
Financial Modeling
Market Entry
Venture Capital
Business Strategy
Executive Management
Cross-functional Team Leadership
Emerging Markets
Entrepreneurship
Management
Mergers & Acquisitions
Strategic Planning
Valuation

Education

Work Experience

  • Partner

    2021

    Flare Capital Partners is a leading healthcare technology and services venture capital firm based in Boston, MA. Flare Capital Partners has invested in Aetion, Aspen RxHealth, Axuall, BeMe Health, Bright Health (IPO), Cayaba Care, Circulation (acquired by LogistiCare), ClearDATA, Cohere Health, Curisium (acquired by R1), Eden Health, Elektra Health, HealthReveal, HealthVerity, higi, Iora Health (acquired by One Medical), Lumify Care, Marigold Health, Oshi Health, Oui Health, Somatus, Suki, Tausight, Valence Health (acquired by Evolent Health), VisitPay, Votitve, and Welltok. Flare Scholar Ventures (FSV) investments include EarlyBird Educations, Lumify Care, Piction Health, Revea, UnifiHealth, and Vincere Health. Co-led/led and/or supported Flare investments in Cayaba Care, EarlyBird Educations, Lumify Care, Somatus, Oshi Health, and Vincere Health. Supported various Strategic LP (including leading health plans and health systems) management initiatives.

  • Principal

    2019 - 2021

  • Board Member

    2024

    The NEVCA fosters a collaborative, inclusive, and prosperous innovation ecosystem on behalf of New England's VC industry. Operating across four pillars - Venture Community, Regional Brand, Workforce Development, and Public Policy - the association's initiatives impact the community at large: events connect founders, funders, and innovators; legislative advocacy promotes economic growth; programs bolster professional development across the venture landscape.

  • Board Member

    2023

  • Board Member

    2022

  • Board Member (Observer)

    2022

    Transition from BoD Director to Observer after Series B financing.

  • Board Observer

    2021

2021 - 2023

  • Board Observer

    2021 - 2023

    [Acquired by RVO Health]

2021 - 2022

  • Board Observer

    2021 - 2022

  • Board Observer

    2020 - 2022

2019 - 2021

  • Investor Advisory Board Member

    2019 - 2021